Nomura Shosaku
Division of Hematology, Kishiwada City Hospital, Kishiwada 596-8501.
Rinsho Byori. 2005 Jul;53(7):617-21.
Drug-induced thrombocytopenia is common, but most previous reports do not present evidence for drugs as a definite or probable cause of the thrombocytopenia. The important diagnostic issue is to distinguish between drug-induced thrombocytopenia and idiopathic thrombocytopenic purpura, because the latter diagnosis requires the exclusion of other causes of thrombocytopenia. Drug-induced thrombocytopenia includes at least three mechanisms, such as marrow suppression, immunological, and nonimmunological thrombocytopenia. In immunological thrombocytopenia, demonstration of drug-dependent antiplatelet antibodies was included as evidence confirming the causal role of a drug. However, there are no standard assays for drug-dependent antiplatelet antibodies, no standard criteria for distinguishing positive from negative results, and no data on the sensitivity and specificity of these assays based on clinical criteria for a causal relation. Nonimmunological thrombocytopenia includes heparin-dependent thrombocytopenia and thrombotic thrombocytopenic purpura.
药物性血小板减少症很常见,但以前的大多数报告并未提供证据证明药物是血小板减少症的确切或可能病因。重要的诊断问题是区分药物性血小板减少症和特发性血小板减少性紫癜,因为后者的诊断需要排除其他血小板减少症病因。药物性血小板减少症至少包括三种机制,如骨髓抑制、免疫性和非免疫性血小板减少症。在免疫性血小板减少症中,证明药物依赖性抗血小板抗体被视为确认药物因果作用的证据。然而,目前尚无针对药物依赖性抗血小板抗体的标准检测方法,没有区分阳性和阴性结果的标准标准,也没有基于因果关系临床标准的这些检测方法的敏感性和特异性数据。非免疫性血小板减少症包括肝素依赖性血小板减少症和血栓性血小板减少性紫癜。